Atlas Trials

Additive Anti-inflammatory Action for Critically Ill Patients With Cardiovascular Surgery (Xuebijing) IV

Clinical trial NCT04993794 · UNKNOWN

Trial details

NCT number
NCT04993794
Sponsor
Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cardiovascular DiseaseAortic DissectionCoronary Artery DiseaseValve Heart DiseaseCongenital Heart DiseaseCritical Illness
Start date
2021-01-01
Primary completion
2022-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.